Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

被引:291
作者
Feldstein, AE [1 ]
Canbay, A [1 ]
Guicciardi, ME [1 ]
Higuchi, H [1 ]
Bronk, SF [1 ]
Gores, GJ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
obesity; non-alcoholic fatty liver disease; fatty acids; Fas (CD95); apoptosis;
D O I
10.1016/S0168-8278(03)00460-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Hepatic steatosis sensitizes the liver to injury and inflammation by unclear mechanisms. Because Fas has been linked to liver injury and inflammation, Fas expression and sensitization to Fas signaling was examined in models of hepatic steatosis. Methods: Mice were fed a carbohydrate diet while control animals received standard chow. Sensitization to Fas was examined following administration of Jo2 antibody. For the in vitro experiments, HepG2 cells were incubated with or without a mixture of long chain fatty acids (2:1 oleate:palmitate). Sensitization of the cells to Fas was examined using the CH11 antibody. Results: Mice fed a high caloric diet developed hepatic steatosis, hyperlipidemia, insulin resistance, and hyperleptinemia, all features of the human syndrome. Fas expression in hepatocytes was increased as compared to lean animals and was coupled to cytotoxic signaling. Indeed, hepatocyte apoptosis, liver injury and chemokine generation were all accentuated in obese animals following administration of Jo-2, a Fas agonist. Hep G2 cells cultured in the presence of free fatty acids also developed 'cellular steatosis', upregulated Fas expression and were more sensitive to apoptosis by a Fas agonist. Conclusions: Collectively, these data implicate Fas as a link between obesity associated fatty liver and increased susceptibility to liver damage. (C) 2003 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:978 / 983
页数:6
相关论文
共 32 条
  • [1] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 30 (06) : 1356 - 1362
  • [2] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [3] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [4] NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY
    BACON, BR
    FARAHVASH, MJ
    JANNEY, CG
    NEUSCHWANDERTETRI, BA
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1103 - 1109
  • [5] Body-mass index and mortality in a prospective cohort of US adults
    Calle, EE
    Thun, MJ
    Petrelli, JM
    Rodriguez, C
    Heath, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) : 1097 - 1105
  • [6] Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis
    Canbay, A
    Higuchi, H
    Bronk, SF
    Taniai, M
    Sebo, TJ
    Gores, GJ
    [J]. GASTROENTEROLOGY, 2002, 123 (04) : 1323 - 1330
  • [7] NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
    Chitturi, S
    Abeygunasekera, S
    Farrell, GC
    Holmes-Walker, J
    Hui, JM
    Fung, C
    Karim, R
    Lin, R
    Samarasinghe, D
    Liddle, C
    Weltman, M
    George, J
    [J]. HEPATOLOGY, 2002, 35 (02) : 373 - 379
  • [8] Etiopathogenesis of nonalcoholic steatohepatitis
    Chitturi, S
    Farrell, GC
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 27 - 41
  • [9] Clinical features and natural history of nonalcoholic steatosis syndromes
    Falck-Ytter, Y
    Younossi, ZM
    Marchesini, G
    McCullough, AJ
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 17 - 26
  • [10] Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway
    Faouzi, S
    Burckhardt, BE
    Hanson, JC
    Campe, CB
    Schrum, LW
    Rippe, RA
    Maher, JJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) : 49077 - 49082